{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibgxcj5unjpx5x6pjfnp3l3rbfwmk74cc6rilgx2pj4icgzp45sgu",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3melchnmvreh2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibuqzmzz244vud5um46hiigbaolpjr6rpwpavfplqrmxq25wl7une"
    },
    "mimeType": "image/jpeg",
    "size": 63895
  },
  "path": "/2026/02/11/hims-federal-scrutiny-impact-on-telehealth-compounding-pharmacies/?utm_campaign=rss",
  "publishedAt": "2026-02-11T09:30:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Business",
    "Health tech",
    "Pharmaceuticals",
    "STAT+",
    "Telehealth"
  ],
  "textContent": "A federal regulatory crackdown on Hims could impact a broader network of compounding pharmacies and telehealth companies.",
  "title": "STAT+: Hims is in the crosshairs. Is a crackdown coming for compounding?",
  "updatedAt": "2026-02-11T01:57:14.000Z"
}